DEEP ISOLATION NUCLEAR (DBHL) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DBHL SEC filings page.
DEEP ISOLATION NUCLEAR (DBHL) reported $6.1M in revenue for fiscal year 2025, down 13.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue contracted, but a much larger overhead base turned improved gross margin into sharply deeper losses and cash outflows.
Gross margin expanded from48.0% in FY2024 to57.1% in FY2025 even as revenue fell13.0% ; however, SG&A rose to$8.8M , so the business retained more from each sale but spent much more overall to operate. That combination pushed the operating margin from-15.1% to-94.0% , indicating cost growth—not weak product-level gross economics—drove the deterioration.
Profit and cash flow moved together negatively: the net loss widened from
The balance sheet expanded through financing rather than operations. Financing provided
Financial Health Signals
DEEP ISOLATION NUCLEAR does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
DEEP ISOLATION NUCLEAR passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
DEEP ISOLATION NUCLEAR reported a net loss of $5.3M while operations used $3.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
DEEP ISOLATION NUCLEAR reported an operating loss of $5.8M against $1K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
DEEP ISOLATION NUCLEAR generated $1.3M in revenue in Q2 2026. Against the prior quarter it is down 8.8%.
DEEP ISOLATION NUCLEAR's EBITDA was -$3.2M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. Against the prior quarter it is up 42.1%.
DEEP ISOLATION NUCLEAR reported -$3.0M in net income in Q2 2026. Against the prior quarter it is up 43.9%.
DEEP ISOLATION NUCLEAR earned -$0.05 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 44.4%.
Cash & Balance Sheet
DEEP ISOLATION NUCLEAR recorded an outflow of $2.9M in free cash flow in Q2 2026, representing a cash shortfall after capex. Against the prior quarter it is up 45.6%.
DEEP ISOLATION NUCLEAR held $19.4M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
DEEP ISOLATION NUCLEAR's gross margin was 53.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. Against the prior quarter it is up 0.7 percentage points.
DEEP ISOLATION NUCLEAR's ROE was -15.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is up 8.8 percentage points.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
DEEP ISOLATION NUCLEAR invested $1.2M in research and development in Q2 2026. Against the prior quarter it is down 66.2%.
DEEP ISOLATION NUCLEAR invested $57K in capex in Q2 2026, funding long-term assets and infrastructure. Against the prior quarter it is up 235.3%.
Not reported for Q2 2026.
DBHL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $1.4M-4.8% | $6.1M-13.0% | $1.7M | N/A | $1.5M | $7.1M | N/A |
| Cost of Revenue | $612K | $681K+2.9% | N/A | $700K | N/A | $662K | N/A | N/A |
| Gross Profit | $707K | $766K-10.7% | N/A | $983K | N/A | $858K | N/A | N/A |
| R&D Expenses | $1.2M | $3.5M | N/A | N/A | $0 | $0 | N/A | N/A |
| SG&A Expenses | $2.7M | $2.8M+186.0% | N/A | $2.5M | N/A | $993K+8853.2% | N/A | N/A |
| Operating Income | -$3.2M | -$5.6M-3307.3% | N/A | -$1.5M | N/A | -$164K-1378.7% | N/A | N/A |
| EBITDA | -$3.2M | -$5.6M-4020.7% | N/A | -$1.5M | N/A | -$135K | N/A | N/A |
| Interest Expense | N/A | $1K | N/A | N/A | N/A | $0 | N/A | N/A |
| Income Tax | $0 | $0-100.0% | N/A | N/A | $0 | $1K | N/A | N/A |
| Net Income | -$3.0M | -$5.4M-3162.7% | N/A | -$1.3M | N/A | -$166K | N/A | N/A |
| EPS (Basic) | -$0.05-66.7% | -$0.09 | -$0.05-400.0% | -$0.02 | -$0.03 | $0.00 | -$0.01 | $0.00 |
| EPS (Diluted) | -$0.05 | -$0.09 | -$0.05 | -$0.02 | -$0.03 | $0.00 | -$0.01 | $0.00 |
| Diluted Shares (Avg) | 58M | 58M | N/A | 54M | 42M+743.0% | 41M+714.7% | N/A | 44M+784.0% |
DBHL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.6M+235200.5% | $24.8M+637.1% | $29.6M+617.3% | $31.6M+1411617.4% | $9K+217.5% | $3.4M+28285.6% | $4.1M+169998.8% | $2K-28.8% |
| Current Assets | $20.9M+227527.4% | $24.1M+615.9% | $28.8M+763.1% | $30.9M+1382413.4% | $9K+217.5% | $3.4M+28285.6% | $3.3M+137420.6% | $2K-28.8% |
| Cash & Equivalents | $19.4M+210518.4% | $22.2M+561.5% | $27.4M+1176.6% | $28.2M+1261483.2% | $9K+217.5% | $3.4M+28285.6% | $2.1M | $2K-28.8% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $465K | $593K | $439K-56.1% | $1.5M | N/A | N/A | $999K | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $182K | $182K | $182K0.0% | $182K | N/A | N/A | $182K | N/A |
| Total Liabilities | $2.0M+211.0% | $2.4M+1358.4% | $2.4M+100.1% | $2.1M+158.2% | -$1.8M+45.9% | $166K+104.7% | $1.2M+137.8% | -$3.6M-3698.5% |
| Current Liabilities | $1.9M+929.2% | $2.3M+1282.3% | $2.3M+145.2% | $1.9M+1232.4% | $184K+38.8% | $166K+26.8% | $924K+739.8% | $143K+42.6% |
| Non-Current Liabilities | $91K+104.6% | $126K | $161K-44.3% | $194K+105.2% | -$2.0M+42.7% | $0+100.0% | $289K+108.7% | -$3.7M |
| Total Equity | $19.7M+995.0% | $22.4M+699.5% | $27.2M+832.3% | $29.5M+719.1% | $1.8M-45.7% | $2.8M-20.7% | $2.9M-9.1% | $3.6M+3817.5% |
| Retained Earnings | -$41.0M-23272.9% | -$37.9M+76.7% | -$32.5M-19.6% | -$30.0M-21210.6% | -$175K-34.7% | -$162.7M-136377.7% | -$27.2M-25032.1% | -$141K-44.7% |
Not reported in any period shown, so not listed: Inventory, Long-Term Debt.
DBHL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.8M | -$5.2M-43783.3% | -$701K-42.5% | -$2.6M | N/A | $12K+2130.5% | -$492K-4493.4% | N/A |
| Depreciation & Amortization | $25K-16.7% | $25K-13.8% | N/A | $29K | $30K | $29K | N/A | N/A |
| Stock-Based Compensation | N/A | $522K+1988.0% | N/A | N/A | N/A | $25K | N/A | N/A |
| Capital Expenditures | $57K | $17K-45.2% | $67K | $7K | $0 | $31K | N/A | N/A |
| Free Cash Flow | -$2.9M | -$5.3M-27578.9% | -$768K | -$2.6M | N/A | -$19K | N/A | N/A |
| Investing Cash Flow | -$30K | -$17K+45.2% | -$67K | $0 | $0 | -$31K | N/A | N/A |
| Financing Cash Flow | $0 | $3K-95.7% | -$3K-200.0% | $28.8M | N/A | $69K+590.0% | -$1K-110.0% | N/A |
| Share Buybacks | N/A | N/A | $0 | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
DBHL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.6% | 52.9%-3.5pp | N/A | 58.4% | N/A | 56.5% | N/A | N/A |
| Operating Margin | -245.9% | -386.2% | N/A | -91.4% | N/A | -10.8% | N/A | N/A |
| Net Margin | -230.2% | -374.3% | N/A | -77.7% | N/A | -10.9% | N/A | N/A |
| Return on Equity | -15.4% | -24.2%-18.3pp | N/A | -4.4% | N/A | -5.9% | N/A | N/A |
| Return on Assets | -14.0% | -21.9%-16.9pp | N/A | -4.1% | N/A | -4.9% | N/A | N/A |
| Current Ratio | 11.06+11.0x | 10.51-9.8x | 12.72+9.1x | 16.28+16.3x | 0.050.0x | 20.30+20.2x | 3.61+3.6x | 0.020.0x |
| Debt-to-Equity | 0.10 | 0.110.0x | 0.09-0.3x | 0.07 | N/A | 0.06 | 0.42 | N/A |
| Asset Turnover | 0.06 | 0.06-0.4x | 0.21-1.5x | 0.05 | N/A | 0.45 | 1.71 | N/A |
| FCF Margin | -216.8% | -363.4% | -12.5% | -155.6% | N/A | -1.3% | N/A | N/A |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Where DEEP ISOLATION NUCLEAR Ranks
Frequently Asked Questions
What is DEEP ISOLATION NUCLEAR's annual revenue?
DEEP ISOLATION NUCLEAR (DBHL) reported $6.1M in total revenue for fiscal year 2025. This represents a -13.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is DEEP ISOLATION NUCLEAR's revenue growing?
DEEP ISOLATION NUCLEAR (DBHL) revenue declined by 13.0% year-over-year, from $7.1M to $6.1M in fiscal year 2025.
Is DEEP ISOLATION NUCLEAR profitable?
No, DEEP ISOLATION NUCLEAR (DBHL) reported a net income of -$5.3M in fiscal year 2025, with a net profit margin of -87.0%.
What is DEEP ISOLATION NUCLEAR's EBITDA?
DEEP ISOLATION NUCLEAR (DBHL) had EBITDA of -$5.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is DEEP ISOLATION NUCLEAR's gross margin?
DEEP ISOLATION NUCLEAR (DBHL) had a gross margin of 57.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is DEEP ISOLATION NUCLEAR's operating margin?
DEEP ISOLATION NUCLEAR (DBHL) had an operating margin of -94.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is DEEP ISOLATION NUCLEAR's net profit margin?
DEEP ISOLATION NUCLEAR (DBHL) had a net profit margin of -87.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is DEEP ISOLATION NUCLEAR's return on equity (ROE)?
DEEP ISOLATION NUCLEAR (DBHL) has a return on equity of -19.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is DEEP ISOLATION NUCLEAR's free cash flow?
DEEP ISOLATION NUCLEAR (DBHL) recorded an outflow of $4.0M in free cash flow during fiscal year 2025. This represents a -236.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is DEEP ISOLATION NUCLEAR's operating cash flow?
DEEP ISOLATION NUCLEAR (DBHL) recorded an outflow of $3.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are DEEP ISOLATION NUCLEAR's total assets?
DEEP ISOLATION NUCLEAR (DBHL) had $29.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are DEEP ISOLATION NUCLEAR's capital expenditures?
DEEP ISOLATION NUCLEAR (DBHL) invested $105K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does DEEP ISOLATION NUCLEAR spend on research and development?
DEEP ISOLATION NUCLEAR (DBHL) invested $404K in research and development during fiscal year 2025.
What is DEEP ISOLATION NUCLEAR's current ratio?
DEEP ISOLATION NUCLEAR (DBHL) had a current ratio of 12.72 as of fiscal year 2025, which is generally considered healthy.
What is DEEP ISOLATION NUCLEAR's debt-to-equity ratio?
DEEP ISOLATION NUCLEAR (DBHL) had a debt-to-equity ratio of 0.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is DEEP ISOLATION NUCLEAR's return on assets (ROA)?
DEEP ISOLATION NUCLEAR (DBHL) had a return on assets of -18.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is DEEP ISOLATION NUCLEAR's Piotroski F-Score?
DEEP ISOLATION NUCLEAR (DBHL) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are DEEP ISOLATION NUCLEAR's earnings high quality?
DEEP ISOLATION NUCLEAR (DBHL) reported a net loss of $5.3M while operations used $3.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can DEEP ISOLATION NUCLEAR cover its interest payments?
DEEP ISOLATION NUCLEAR (DBHL) reported an operating loss of $5.8M against $1K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.